GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 14.63
+0.52 (3.69%)
Mar 27, 2026, 4:00 PM EDT
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 6 billion as of March 27, 2026. Its market cap has decreased by -3.71% in one year.
Market Cap
6.00B
Enterprise Value
5.13B
Revenue
793.25M
Ranking
n/a
PE Ratio
41.80
Stock Price
14.63
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 6.00B, a decrease of -20.92%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.00B | -4.75% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 6.82B |
| Jiangsu Aidea Pharmaceutical Group | 6.74B |
| Shenzhen Weiguang Biological Products | 6.24B |
| Xiangxue Pharmaceutical | 6.23B |
| Lifecome Biochemistry | 5.92B |
| R&G PharmaStudies | 5.91B |
| Beijing Konruns Pharmaceutical | 5.85B |
| Shanghai OPM Biosciences | 5.80B |